NCT06855134View on ClinicalTrials.gov

Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in Advanced Rare Cancers

Not yet recruitingOBSERVATIONAL
Enrollment

946

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

April 30, 2029

Study Completion Date

April 30, 2030

Conditions
Rare Cancer
All Listed Sponsors
collaborator

NCT Berlin: Charité- Universitätsmedizin Berlin

UNKNOWN

collaborator

NCT Dresden: University Hospital Dresden

UNKNOWN

collaborator

NCT Heidelberg: University Hospital Heidelberg

UNKNOWN

collaborator

NCT WERA: University Hospital Würzburg, University Hospital Erlangen, University Hospital Regensburg, University Hospital Augsburg

UNKNOWN

collaborator

NCT West: University Hospital Cologne, University Hospital Essen

UNKNOWN

collaborator

NCT Southwest: University Hospital Tübingen, Robert-Bosch-Hospital Stuttgart, University Hospital Ulm

UNKNOWN

lead

German Cancer Research Center

OTHER